Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD
Brendon Neuen, MBBS, PhD, joins hosts to discuss the landmark FLOW trial and its implications on the future of chronic kidney disease management as well as other compelling data surrounding semaglutide from the 61st European Renal Association Congress. Key Highlights: 00:00 - Intro 01:12 - ERA Recap 03:06 - FLOW Background 05:20 - FLOW Results 06:56 - FLOW Reaction (Neuen) 09:13 - Semaglutide Mortality Benefit 12:43 - Semaglutide 2.4 in CKD 17:30 - Implementation Science 22:30 - Management Approach